Galapagos NV Signs New Compound Management Agreement

MECHELEN, BELGIUM--(Marketwire - June 30, 2008) - 30 June 2008 - Galapagos NV (Euronext: GLPG) announces today that its service division BioFocus DPI will provide compound management and related services to Sepracor Inc. (NASDAQ: SEPR), a leader in respiratory and central nervous system disorder medicines. Total contract value for Galapagos is EUR 1 million ($1.5 million). Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor's proprietary compound library, and plate and replicate these compounds for a period of three years. Services will be provided by BioFocus DPI's compound management facility in South San Francisco, USA.